Hamish Philpott

ORCID: 0000-0002-1973-6355

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Etrasimod as a treatment for eosinophilic oesophagitis (VOYAGE): a double-blind, placebo-controlled, randomised, phase 2 trial”.

Etrasimod as a treatment for eosinophilic oesophagitis (VOYAGE): a double-blind, placebo-controlled, randomised, phase 2 trial

The Lancet. Gastroenterology & hepatology(2025)10.1016/s2468-1253(25)00062-7

N/A

0.473DataRank · unranked

15 citations

Margaret H. Collins, Albert J. Bredenoord, Hamish Philpott, Luc Biedermann, Márjori Dulcine +11 more

Effect of Proton Pump Inhibitor Treatment in “PPI Non-responsive” Patients with Eosinophilic Esophagitis

Journal of Gastrointestinal and Liver Diseases(2023)10.15403/jgld-4746

N/A

0DataRank · unranked

12 citations

Hamish Philpott, Sean LaFata, Mark R. Fowler, Staci Keene, Alina C. Iuga +2 more